INFINITY PHARMACEUTICALS, INC.·4

Apr 2, 8:22 PM ET

BEIER DAVID W 4

4 · INFINITY PHARMACEUTICALS, INC. · Filed Apr 2, 2018

Insider Transaction Report

Form 4
Period: 2018-04-01
Transactions
  • Award

    Stock Option (right to buy)

    2018-04-01+40,00040,000 total
    Exercise: $2.10Exp: 2028-04-01Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Represents the closing sale price per share of the Issuer's common stock as reported on the Nasdaq Global Select Market on the trading day immediately prior to the date of grant.
  • [F2]The option vests as to 1/8th of the shares on June 30, 2018 and as to 1/8th of the shares at the end of each calendar quarter thereafter, provided that the holder continues to serve as a director of the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION